Crawford, 1999 - Google Patents
Epstein–Barr virusCrawford, 1999
- Document ID
- 17694475091038558037
- Author
- Crawford D
- Publication year
- Publication venue
- Principles and practice of clinical virology
External Links
Snippet
Summary The discovery of Epstein‐Barr virus (EBV) in 1964 resulted from the description by Denis Burkitt of a geographically restricted tumour occurring in African children. The tumour, which characteristically arises in the jaw, is now known to be of lymphocyte origin and is …
- 241000701044 Human gammaherpesvirus 4 0 title abstract description 110
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N2710/00—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses
- C12N2710/00011—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA dsDNA Viruses dsDNA Viruses
- C12N2710/16011—Herpesviridae
- C12N2710/16611—Simplexvirus, e.g. human herpesvirus 1, 2
- C12N2710/16622—New viral proteins or individual genes, new structural or functional aspects of known viral proteins or genes
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/12—Viral antigens
- A61K39/245—Herpetoviridae, e.g. herpes simplex virus
- A61K39/255—Marek's disease virus
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/06—Animal cells or tissues; Human cells or tissues ; Not used, see subgroups
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
- C12N5/10—Cells modified by introduction of foreign genetic material Not used, see subgroups
- C12N5/12—Fused cells, e.g. hybridomas
- C12N5/16—Animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12N—MICRO-ORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING OR MAINTAINING MICRO-ORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
- C12N7/00—Viruses; Bacteriophages; Compositions thereof; Preparation or purification thereof
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/005—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from viruses
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Young et al. | Epstein–Barr virus: more than 50 years old and still providing surprises | |
Crawford | Epstein–Barr virus | |
Nazerian et al. | A nonproducer T lymphoblastoid cell line from Marek's disease transplantable tumor (JMV) | |
Schat et al. | Transformation of T-lymphocyte subsets by Marek's disease herpesvirus | |
Kaiser‐Mccaw et al. | Chromosome 14 translocation in African and North American Burkitt's lymphoma | |
Epstein et al. | The Epstein-Barr Virus | |
Camacho et al. | Transformation of hamster embryo fibroblasts by a specific fragment of the herpes simplex virus genome | |
Ku et al. | Tropism of varicella-zoster virus for human tonsillar CD4+ T lymphocytes that express activation, memory, and skin homing markers | |
Koropchak et al. | Investigation of varicella-zoster virus infection of lymphocytes by in situ hybridization | |
Skinner | Transformation of primary hamster embryo fibroblasts by type 2 simplex virus: evidence for a" hit and run" mechanism. | |
Epstein et al. | Introduction: discovery and general biology of the virus | |
Haffer et al. | The role of the macrophage in Marek's disease: in vitro and in vivo studies | |
JP2017184745A (en) | Diagnosis of viral infection by detecting genomic dna and infectious viral dna with molecular combing | |
Hahn et al. | Lymphoproliferative diseases of fowl: JM-V leukemic lymphoblasts in cell culture: brief communication | |
Okano | Haematological associations of Epstein–Barr virus infection | |
Harrington et al. | Epstein-Barr virus-associated lymphoproliferative lesions | |
Cermelli et al. | Growth of human herpesvirus 6 in HEPG2 cells | |
Ablashi et al. | Oncogenic herpesviruses of nonhuman primates | |
Pearson et al. | Antibody patterns to Herpesvirus saimiri-induced antigens in owl monkeys | |
Nazerian | Marek's disease lymphoma of chicken and its causative herpesvirus | |
McKnight et al. | EBV gene expression, EBNA antibody responses and EBV+ peripheral blood lymphocytes in post-transplant lymphoproliferative disease | |
Macsween et al. | Epstein-barr virus (EBV): Infectious mononucleosis and other non-malignant EBV-associated diseases | |
Kasprzak et al. | Epstein-Barr virus (EBV) infection in B-cell non-Hodgkin's lymphomas in children: virus latency and its correlation with CD21 and CD23 molecules. | |
Macsween et al. | Human Herpesviruses: Infectious Mononucleosis and Other Non-Malignant Diseases | |
Hayashi et al. | Studies of Latent Cytomegalovirus Infection The Macrophage as a Virus-Harboring Cell |